A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas - Wikidata - wikimedia - TriplyDB

A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas

A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas

http://www.wikidata.org/entity/Q33375377

about

Current clinical trials testing the combination of immunotherapy with radiotherapy.A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma.Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem Synergistic up-regulation of CXCL10 by virus and IFN γ in human airway epithelial cells.Toll-like receptor agonists in cancer therapy.Role of type 1 IFNs in antiglioma immunosurveillance--using mouse studies to guide examination of novel prognostic markers in humans.Immunomodulatory effects of dsRNA and its potential as vaccine adjuvant.Experimental approaches for the treatment of malignant gliomas.Combinations of immunotherapy and radiation in cancer therapy.Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulo Immunotherapy of brain cancers: the past, the present, and future directions.Pediatric phase II trials of poly-ICLC in the management of newly diagnosed and recurrent brain tumors.Microglia isolated from patients with glioma gain antitumor activities on poly (I:C) stimulation.Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells.Inhibition of STAT3 reverses drug resistance acquired in temozolomide-resistant human glioma cells.Trial Watch: Experimental Toll-like receptor agonists for cancer therapy TLR3 agonists improve the immunostimulatory potential of cetuximab against EGFR(+) head and neck cancer cells.TLR3 agonists and proinflammatory antitumor activities.Immunity, immunopathology, and human vaccine development against sexually transmitted Chlamydia trachomatis Smac mimetics and innate immune stimuli synergize to promote tumor death Combinatorial immunotherapy of polyinosinic-polycytidylic acid and blockade of programmed death-ligand 1 induce effective CD8 T-cell responses against established tumors.Ependymomas: development of immunotherapeutic strategies.Immunotherapy approaches for malignant glioma from 2007 to 2009.Stimulating natural killer cells to protect against cancer: recent developments.Vaccine adjuvant uses of poly-IC and derivatives.Novel chemotherapeutics and other therapies for treating high-grade glioma.Poly(I:C)-mediated tumor growth suppression in EGF-receptor overexpressing tumors using EGF-polyethylene glycol-linear polyethylenimine as carrier.Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague.Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomas.A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer.Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study.Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma.Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma.Nucleic acid therapeutics: concepts for targeted delivery to solid tumors Enhancing the immune stimulatory effects of cetuximab therapy through TLR3 signalling in Epstein-Barr virus (EBV) positive nasopharyngeal carcinoma

P2860

Q30356447-E3C1117A-9ACA-4DAF-8438-400AE4A44B6D Q33390586-C315BD42-5DA5-48DB-A68E-F151D3A7E4DE Q33796170-2ADB399D-C01F-440A-B4E1-E78D2245BD67 Q33916203-DDCA386A-A8B9-4F14-938C-99DF996C3531 Q33918509-57E5977F-1C7E-4B72-AE1E-A9D895F79BF8 Q33959111-AAD88120-D6B7-4C64-99F2-2172694C90A5 Q34022013-62F5E38F-AD8D-4360-ADDA-F01024CE4655 Q34127138-52E297CE-972E-453A-AE72-B85901674F74 Q34582640-FFD80DAE-840B-4D51-81C9-BA74B0A49336 Q34666875-AB20CAB0-2478-455A-A483-E514846881C9 Q34701587-A5DD1CD7-10B8-44B7-AF94-266EA3894482 Q35167156-7BFC96E6-B8DE-4FC4-8796-B24F5B376AB3 Q35633823-82910A9E-F4FB-4183-B7AE-9CE0A9EB939E Q36018407-02FF9950-E5A7-4E95-A30F-96BA556BEEF6 Q36142675-2ABC5E97-D828-4662-81BA-3EB3D2DA3C7D Q36194849-AF3F955D-6453-441B-B560-3FEFA95BDB12 Q37028027-00D8FF56-26A5-4132-9B39-96E250448D80 Q37136200-13EFA929-F7ED-4EB7-BF25-5E2149FCB5B6 Q37159712-BE13C089-02ED-493C-B275-04CE136FD651 Q37270377-1A4F56A1-7D7C-470E-8A64-1174583BD27D Q37641401-96FEEF1C-0BD0-49B5-9B80-0E392928E8CA Q37678294-11EB2BBD-AF3B-40FC-857A-BBF3C900645A Q37738055-CD1330E8-3824-427A-B871-C3DC47AF58B7 Q37877269-C37C55E4-A256-45B4-8D43-38747892640B Q38259510-78A45E60-8518-4ADB-AE24-F7675F92CF47 Q38569802-5BEAF831-59B8-47B2-B648-C43CFD490156 Q39669738-74ED593C-6FCA-46E2-B276-D4E31DB645DB Q41432452-270D4A08-7A02-4E90-A9B8-BDB7E86E19E1 Q42431588-E77391FE-280F-490D-8F31-200CBC819ECE Q45073466-6C838D13-1319-4ACA-ACA6-4BDD3D58301A Q45933704-351A5C2F-CBE7-484C-A8DA-7229BA74B9F6 Q55257766-3DD3EC5E-1631-4EF3-9994-7F3D08864772 Q55462717-0183E93D-A998-47A1-BA77-A206FDB2314B Q57372842-94EA5E2F-7280-49CC-AD7E-FCE4D67158C9 Q58129526-5688985C-7D6B-46AF-BA20-1F6B8A8B0BBD

P2860

A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas

http://www.wikidata.org/entity/Q33375377

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

A North American brain tumor c ...... h recurrent anaplastic gliomas

@ast

A North American brain tumor c ...... h recurrent anaplastic gliomas

@en

type

label

A North American brain tumor c ...... h recurrent anaplastic gliomas

@ast

A North American brain tumor c ...... h recurrent anaplastic gliomas

@en

prefLabel

A North American brain tumor c ...... h recurrent anaplastic gliomas

@ast

A North American brain tumor c ...... h recurrent anaplastic gliomas

@en

P1433

Q33375377-78FFEA17-5206-4A45-A424-3031D2C18626

P1476

Q33375377-F6009FCF-E408-4312-84CF-47C941341459

P2093

Q33375377-2389925F-FD74-4DCE-A21C-F663468AFE9A

Q33375377-275CC5CB-8944-4601-95DA-0E6544CAD3F8

Q33375377-5099D3C0-3B1B-4927-9888-8ACC22DBA1C0

Q33375377-7452A465-6426-4442-A445-7A0E6B9951D3

Q33375377-822B7ED6-C1DD-4BC7-A249-E6CCD5F24570

Q33375377-8374E9ED-930B-406B-A98E-21C47756B999

Q33375377-8945F009-D953-48FE-BF31-94C47EEFCCA7

Q33375377-A832D910-D202-4DFB-9CC6-7B42C68667CA

Q33375377-AB5BD570-7929-4989-842F-5196ADBC8AF6

Q33375377-B53E6A37-5983-43FF-8B13-6546E1737DBC

P2860

Q33375377-0E349BF6-C328-4996-8003-75F5EC27CF14

Q33375377-19D4E0EE-8E50-4B2A-8C5C-C767F8D42AA4

Q33375377-27376B8A-2880-4CEF-A254-04C880B44E20

Q33375377-2A0FB199-21B4-4FCD-82C5-FE51D5786398

Q33375377-42FE4900-9D8D-4BA0-A312-1754F9E8C2DB

Q33375377-43F18424-074E-4BA6-84E0-E4B7CE00BE09

Q33375377-4695D386-6B99-44C3-96C7-071CF7159590

Q33375377-476B5D15-57B8-4246-A763-ACC84123F2BA

Q33375377-5A6A49F2-2358-4FE7-84CB-C42CB2AA08DA

Q33375377-5A872D39-4B37-4455-B356-E5092D40D020

P2888

Q33375377-53F58CAE-09A1-4F33-8282-D960424036D5

P304

Q33375377-B9090229-765D-451E-B40C-A70E84110BC7

P31

Q33375377-1C2DAF03-D95C-483A-8BDD-CE5E642B37DA

P356

Q33375377-2E96BE44-C14A-4B94-A107-54B2F6E0BB96

P433

Q33375377-4F5816E6-8CE7-447E-A81E-422D80A1CE7D

P478

Q33375377-B3C33084-D1F6-4909-A72D-A3945297A126

P50

Q33375377-9187E1B9-D23E-4D34-85CE-923C33DA993A

Q33375377-EC074637-B5F6-4876-AAB0-E8163C99A13C

P577

Q33375377-6C716746-95F8-4CD9-BC96-A00DC30FA197

P5875

Q33375377-B97DB637-3B8D-4276-AD7A-4FB1F1149DE1

P6179

Q33375377-F7F60F82-D26D-456E-9267-BDAD8E98DF99

P698

Q33375377-1210F434-14E8-4512-81E9-718CC0A4E7F9

P932

Q33375377-BD8EDB22-7BE2-48D7-B000-A4EDEA3859AE

P356

S11060-008-9705-3

P1433

Journal of Neuro-Oncology

P1476

A North American brain tumor c ...... h recurrent anaplastic gliomas

@en

P2093

Andres M Salazar

http://www.w3.org/2001/XMLSchema#string

Bee L Lee

http://www.w3.org/2001/XMLSchema#string

Frank Lieberman

http://www.w3.org/2001/XMLSchema#string

H Ian Robins

http://www.w3.org/2001/XMLSchema#string

Karen Fink

http://www.w3.org/2001/XMLSchema#string

Kathleen R Lamborn

http://www.w3.org/2001/XMLSchema#string

Larry Junck

http://www.w3.org/2001/XMLSchema#string

Lauren Abrey

http://www.w3.org/2001/XMLSchema#string

Michael D Prados

http://www.w3.org/2001/XMLSchema#string

Nicholas Butowski

http://www.w3.org/2001/XMLSchema#string

P2860

Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials.

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy.

Anaplastic astrocytoma in adults.

Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas

PKR in innate immunity, cancer, and viral oncolysis.

P2888

s11060-008-9705-3

P304

183-189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-008-9705-3

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P50

Lisa M DeAngelis

P577

2008-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23312367

http://www.w3.org/2001/XMLSchema#string

P6179

1002008829

http://www.w3.org/2001/XMLSchema#string

P698

18850068

http://www.w3.org/2001/XMLSchema#string

P932

3104130

http://www.w3.org/2001/XMLSchema#string